Titan Medical (TSX:TMD;OTC:TITFX) announced today that it appointed two new members to its senior leadership team.
Kristen Galfetti will join as VP of investor relations & corporate communications and will be located in Boston, while Chien Huang as been appointed as VP of finance and will be located in Toronto.
Galfetti, a more than 20-year veteran of leading investor relations and corporate communications programs, most recently provided consulting services to small and medium companies in the life science industries, according to a news release.
In addition to her consulting, Galfetti has served as VP of investor relations & corporate communications at Cynapsus Therapeutics. Before that, she held the role of senior director of investor relations at Sanofi. Other companies Galfetti has worked at include AMAG Pharmaceuticals and Genzyme Corporation.
Huang has spent more than 20 years working with the development and implementation of financial models and systems, having most recently served as SVP of corporate finance at Quarterhill.
Other senior roles in finance for Huang came at Aralez Pharmaceuticals and Astellas Pharma.
“It is a pleasure to welcome both Kristen and Chien to Titan Medical. As the Titan team continues to grow and advance our Enos robotic single access surgery system toward human clinical studies, we look forward to these two accomplished leaders significantly contributing to our success,” Titan president & CEO David McNally said in the release. “Kristen and Chien have each demonstrated a record of success in their respective fields, and we are proud that they have joined our leadership team.”